Terms: = Ovarian cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591
55 results:
1. Morphological Changes of the ovarian Vein in Pelvic Venous Disorders.
Nykonenko A; Trailin A; Lazarashvili Z; Proczka RM; Havrylenko B; Nykonenko O
Eur J Vasc Endovasc Surg; 2024 Mar; 67(3):500-505. PubMed ID: 37952635
[TBL] [Abstract] [Full Text] [Related]
2. Impact of Oophorectomy on Survival and Improving Nutritional Status in ovarian Metastasis from Colorectal Adenocarcinoma.
Miyagawa Y; Kitazawa M; Tokumaru S; Nakamura S; Koyama M; Yamamoto Y; Miyazaki S; Hondo N; Soejima Y
Oncology; 2024; 102(2):114-121. PubMed ID: 37699374
[TBL] [Abstract] [Full Text] [Related]
3. The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis.
Hendrikse CSE; Theelen PMM; van der Ploeg P; Westgeest HM; Boere IA; Thijs AMJ; Ottevanger PB; van de Stolpe A; Lambrechts S; Bekkers RLM; Piek JMJ
Gynecol Oncol; 2023 Apr; 171():83-94. PubMed ID: 36841040
[TBL] [Abstract] [Full Text] [Related]
4. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis.
Kim SI; Kim JH; Lee S; Cho H; van Driel WJ; Sonke GS; Bristow RE; Park SY; Fotopoulou C; Lim MC
Gynecol Oncol; 2022 Dec; 167(3):547-556. PubMed ID: 36273925
[TBL] [Abstract] [Full Text] [Related]
5. Increased mortality and non-cancer morbidity risk may be associated with early menopause and varies with aetiology: An exploratory population-based study using data-linkage.
Thong EP; Hart RJ; Teede HJ; Vincent AJ; Enticott JC
Maturitas; 2022 Oct; 164():60-66. PubMed ID: 35803198
[TBL] [Abstract] [Full Text] [Related]
6. miRNA-122-5p in POI ovarian-derived exosomes promotes granulosa cell apoptosis by regulating bcl9.
Zhang X; Zhang R; Hao J; Huang X; Liu M; Lv M; Su C; Mu YL
Cancer Med; 2022 Jun; 11(12):2414-2426. PubMed ID: 35229987
[TBL] [Abstract] [Full Text] [Related]
7. The Correlation between YAP and RhoA Expression in Prostate and ovarian Tumor Stroma.
Lee MJ; Kim D
Asian Pac J Cancer Prev; 2022 Jan; 23(1):281-285. PubMed ID: 35092398
[TBL] [Abstract] [Full Text] [Related]
8. Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer.
Manning-Geist BL; Gordhandas SB; Giri DD; Iasonos A; Zhou Q; Girshman J; O'Cearbhaill RE; Zamarin D; Lichtman SM; Sabbatini PJ; Tew WP; Li K; McDonnell AS; Aviki EM; Chi DS; Aghajanian CA; Grisham RN
Gynecol Oncol; 2022 Jan; 164(1):12-17. PubMed ID: 34763937
[TBL] [Abstract] [Full Text] [Related]
9. Self-organising human gonads generated by a Matrigel-based gradient system.
Oliver E; Alves-Lopes JP; Harteveld F; Mitchell RT; Åkesson E; Söder O; Stukenborg JB
BMC Biol; 2021 Sep; 19(1):212. PubMed ID: 34556114
[TBL] [Abstract] [Full Text] [Related]
10. Cost-effectiveness of olaparib maintenance therapy when used with and without restriction by
Cheng LJ; Wong G; Chay WY; Ngeow J; Tan Y; Soon SS; Aziz MIA; Pearce F; Ng K
Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):441-448. PubMed ID: 33593205
[No Abstract] [Full Text] [Related]
11. Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (
Hall MJ; Bernhisel R; Hughes E; Larson K; Rosenthal ET; Singh NA; Lancaster JM; Kurian AW
Cancer Prev Res (Phila); 2021 Apr; 14(4):433-440. PubMed ID: 33509806
[TBL] [Abstract] [Full Text] [Related]
12. Economic impact of multigene panel testing for hereditary breast and ovarian cancer.
Byfield SD; Wei H; DuCharme M; Lancaster JM
J Comp Eff Res; 2021 Feb; 10(3):207-217. PubMed ID: 33491479
[No Abstract] [Full Text] [Related]
13. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and ovarian cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
Patel AP; Wang M; Fahed AC; Mason-Suares H; Brockman D; Pelletier R; Amr S; Machini K; Hawley M; Witkowski L; Koch C; Philippakis A; Cassa CA; Ellinor PT; Kathiresan S; Ng K; Lebo M; Khera AV
JAMA Netw Open; 2020 Apr; 3(4):e203959. PubMed ID: 32347951
[TBL] [Abstract] [Full Text] [Related]
14. Expression of L1 retrotransposon open reading frame protein 1 in gynecologic cancers.
Xia Z; Cochrane DR; Tessier-Cloutier B; Leung S; Karnezis AN; Cheng AS; Farnell DA; Magrill J; Schmidt D; Kommoss S; Kommoss FKF; Kommoss F; McAlpine JN; Gilks CB; Koebel M; Rabban JT; Huntsman DG
Hum Pathol; 2019 Oct; 92():39-47. PubMed ID: 31220479
[TBL] [Abstract] [Full Text] [Related]
15. Increased expression of plakophilin 3 is associated with poor prognosis in ovarian cancer.
Qian H; Yuan D; Bao J; Liu F; Zhang W; Yang X; Han G; Huang J; Sheng H; Yu H
Medicine (Baltimore); 2019 Mar; 98(10):e14608. PubMed ID: 30855445
[TBL] [Abstract] [Full Text] [Related]
16. Mechanism of Low Expression of miR-30a-5p on Epithelial-Mesenchymal Transition and Metastasis in ovarian cancer.
Wang L; Zhao S; Yu M
DNA Cell Biol; 2019 Apr; 38(4):341-351. PubMed ID: 30839226
[TBL] [Abstract] [Full Text] [Related]
17. Postoperative chemotherapy had no prognostic effect on early-staged young ovarian cancer with unilateral resection.
Zhang X; Wang S; Zhao S; Sun Y; Yang G
Cancer Med; 2018 Nov; 7(11):5488-5496. PubMed ID: 30306725
[TBL] [Abstract] [Full Text] [Related]
18. Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes.
Meyer LA; Lasala J; Iniesta MD; Nick AM; Munsell MF; Shi Q; Wang XS; Cain KE; Lu KH; Ramirez PT
Obstet Gynecol; 2018 Aug; 132(2):281-290. PubMed ID: 29995737
[TBL] [Abstract] [Full Text] [Related]
19. White Blood Cell BRCA1 Promoter Methylation Status and ovarian cancer Risk.
Lønning PE; Berge EO; Bjørnslett M; Minsaas L; Chrisanthar R; Høberg-Vetti H; Dulary C; Busato F; Bjørneklett S; Eriksen C; Kopperud R; Axcrona U; Davidson B; Bjørge L; Evans G; Howell A; Salvesen HB; Janszky I; Hveem K; Romundstad PR; Vatten LJ; Tost J; Dørum A; Knappskog S
Ann Intern Med; 2018 Mar; 168(5):326-334. PubMed ID: 29335712
[TBL] [Abstract] [Full Text] [Related]
20. Primary Immunoprevention of Epithelial ovarian Carcinoma by Vaccination against the Extracellular Domain of Anti-Müllerian Hormone Receptor II.
Mazumder S; Johnson JM; Swank V; Dvorina N; Martelli E; Ko J; Tuohy VK
Cancer Prev Res (Phila); 2017 Nov; 10(11):612-624. PubMed ID: 29093011
[TBL] [Abstract] [Full Text] [Related]
[Next]
